Aminocaproic acid and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Aminocaproic acid (aminocaproic acid), especially for people who are male, 60+ old, also take Furosemide, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Nosebleed when taking Aminocaproic acid. It is created by eHealthMe based on reports of 726 people who have side effects when taking Aminocaproic acid from the FDA, and is updated regularly.

What is Aminocaproic acid?

Aminocaproic acid has active ingredients of aminocaproic acid. eHealthMe is studying from 727 Aminocaproic acid users. Check the latest studies of Aminocaproic acid.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 20, 2026

726 people reported to have side effects when taking Aminocaproic acid.
Among them, 20 people (2.75%) have Nosebleed.

Could Aminocaproic acid cause Nosebleed?

Among these 20 people:

What is the gender of people who have Nosebleed when taking Aminocaproic acid? *

female: 30 %
male: 70 %

What is the age of people who have Nosebleed when taking Aminocaproic acid? *

What are other drugs people take besides Aminocaproic acid? *

Furosemide: 4 people, 20.00%
Combivent: 3 people, 15.00%
Hemlibra: 3 people, 15.00%
Heparin: 3 people, 15.00%
Metoprolol Succinate: 3 people, 15.00%
Nplate: 2 people, 10.00%
Pregabalin: 2 people, 10.00%
Pramipexole Dihydrochloride: 2 people, 10.00%
Pantoprazole: 2 people, 10.00%
Coumadin: 2 people, 10.00%

What are other side effects people have besides Nosebleed? *

Thrombocytopenia (decrease of platelets in blood): 11 people, 55.00%
Melaena (the passage of black, tarry stools): 4 people, 20.00%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 4 people, 20.00%
Fatigue (feeling of tiredness): 4 people, 20.00%
Mouth Haemorrhage (bleeding from mouth): 3 people, 15.00%
Dyspnea (difficult or laboured breathing): 3 people, 15.00%
Anaemia (lack of blood): 3 people, 15.00%
Haemoglobin Decreased: 3 people, 15.00%
Dizziness: 3 people, 15.00%
Fainting (loss of consciousness and postural tone): 2 people, 10.00%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 20.00%
Anaemia (lack of blood): 3 people, 15.00%
High Blood Pressure: 3 people, 15.00%
Iron Overload: 2 people, 10.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 10.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 10.00%
Depression: 2 people, 10.00%
Dry Eyes (lack of adequate tears): 2 people, 10.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aminocaproic acid and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aminocaproic acid:

Aminocaproic acid (727 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Aminocaproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,080 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,093 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aminocaproic acid (the active ingredients of Aminocaproic acid) and Aminocaproic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.